Condition
Focal Hand Dystonia
Total Trials
6
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 3 (1)
Trial Status
Completed4
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT03977493Phase 3RecruitingPrimary
IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia
NCT00325091CompletedPrimary
Long-Term Motor Learning in Focal Hand Dystonia
NCT03664375Not ApplicableCompletedPrimary
Impact Of Physiotherapy And Botox In Improving Functional Outcomes Among Post Stroke Focal Dystonia Patients
NCT00106782Phase 2Completed
Transcranial Electrical Polarization to Treat Focal Hand Dystonia
NCT00376753CompletedPrimary
Muscle Contraction in Patients With Focal Hand Dystonia
NCT00579033Not ApplicableUnknownPrimary
Somatosensory Processing in Focal Hand Dystonia
Showing all 6 trials